TENNOR THERAP-B
0687218AListed醫療健康 · TenNor Therapeutics是一家专注于创新药物研发的中国生物制药公司。
High attention
82.9
/100
- Offer price
- HK$75.70
- Final offer price
- HK$75.70
- Lot / entry fee
- 50 shares · HK$4K
- Proceeds
- HK$670.4M
- Sponsor
- CITIC Securities / ABCI Capital
- Est. margin oversub.
- 7395.4x
- Public oversub.
- 9015.1x
- One-lot win rate
- 0.8%
- First-day return
- +178.7%
Offer starts
May 14
Offer closes
May 19
Grey market
May 21
Listing
May 22
AI reference scoring and scenarios
After grey market
After grey market L1 heat score
82.9/ 100
Data coverage High
Target
Historical calibration
Listing-day trend
Strong positivePartial basis
Up probability
97.5%
First-day reference range
+72.3% – +153.5%
Published outcome check
First-day resultBig up+178.7%
Our call: Trend call valid
Covered 16/25 core factors
UsedMissingNot yet scorableN/A
Margin oversubscription
High heatOffer size
Good qualityCornerstone lockup
—Post-lockup offer value
—Recent same-rule trend
Strong trendRecent same-type trend
Strong trendRecent sector trend
Strong trendValuation
Average appealFundamental quality
Average qualityGrowth quality
—Profitability
Weak qualityCash runway
Weak qualityCustomer concentration
—Cornerstone quality
—Sponsor record
Strong recordGreenshoe arrangementGreenshoe: yes · 15%
Average supportStabilizer track recordCLSA
Strong recordA-share pre-grey trend
—A-share listing-day trend
—Public oversubscription
High heatOne-lot win rate
High heatInternational placing
High heatFinal pricing position
—Actual greenshoe use
—Grey market return
Strong trendThe assessment and probability ranges are informational only and are not investment advice.
AI Research Report
After grey marketThe analysis report for this IPO is being generated.